Clinical efficacy and safety of apatinib combined with S-1 in advanced esophageal squamous cell carcinoma

Background Esophageal cancer is a very common malignant tumor in China, especially esophageal squamous cell carcinoma (ESCC), but there is currently no effective treatment for patients after first-line chemotherapy failure. Apatinib has shown promising outcomes in treatment with various solid tumors...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Invest New Drugs
Главные авторы: Zhao, Jian, Lei, Junmei, Yu, Junyan, Zhang, Chengyan, Song, Xuefeng, Zhang, Ninggang, Wang, Yusheng, Zhang, Suxiang
Формат: Artigo
Язык:Inglês
Опубликовано: Springer US 2019
Предметы:
Phase II Studies
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7066276/
https://ncbi.nlm.nih.gov/pubmed/31650447
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10637-019-00866-5
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы